PRAC meeting highlights 31 August - 3 September 2026
04/09/2026
Medicines for human use
Pharmacovigilance risk assessment committee (PRAC)
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.
Highlights from the September 2026 meeting are now available on the EMA website